| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.6 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |